Blood WBC : 375.0 X 10 9 /l HB : 9.0 g/dl Platelets : 244.000 X 10 9 /l Blasts : 0% no blasts Bone marrow : 8% Hypercellular bone marrow, myeloid hyperplasia with eosinophilia and at least 8% blasts. Erythropoiesis was decreased; megakaryocytes were distributed irregularly with different dysplastic forms. 
Cyto-Pathology Classification

Other molecular cytogenetics results
One split and one fused signals were observed resulting in 1 yellow, 1 red, 1 green, 2 blue conformation (in all bone marrow nuclei).
Other Molecular Studies
Technics: RT-PCR on BCR-ABL. Results: Negative.
Comments
The case described here is of a 19-year-old female who was diagnosed with EMS. It is relatively rare condition characterized in its typical form by the occurence of a bcr/abl-negative myeloproliferative disorder and a lymphoma, usually a precursor T lymphoblastic lymphoma. Cytogenetics revealed a translocation (6;8)(q27;p12) involving the fibroblast growth factor receptor 1 tyrosine kinase gene on chromosome 8p11-12. To our knowledge, only eight cases with the t(6;8)(q27;p12) have been reported previously. Four of these individuals had features at presentation and a clinical course typical of EMS: malignant T-cell lymphoma and CML similar to our case, AML/myeloproliferative disease, CML-like disease with eosinophilia that progressed rapidly to AML and primary AML evolving to EMS following chemotherapy. Of the three remaining individuals, two presented with PV and progressed to AML after a period of 5 years. One case developed PV 2 years after treatment of an MPD and then subsequently progressed to AML. And one patient had features at presentation of FGFR1OP-FGFR1 disease as B-ALL. The myeloid and lymphoid neoplasms with FGFR1 abnormalities are usually ineradicable by conventional chemotherapy but occasional long-term remission patients have been reported following allogeneic bone marrow transplantation.
G-banded partial karyotype showing the t(6;8)(q27;p12).
FISH with the FGFR1 Breakapart probe
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